Search

everythinglearnresearchcommunity

for

Search:↓

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

SkQ1 antioxidant improved health and lifespan in mice.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The document's conclusion cannot be provided because the content is not accessible.

Polyquaternium 7® builds up on hair, improving its look and feel, and AFM is good for measuring these changes.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

ALUDWIG can help standardize female hair loss assessment from a single image.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

The document's content cannot be summarized because it is not accessible or understandable.

Early diagnosis and multidisciplinary care, including orthopedic surgery, can prevent long-term disability in IFAP syndrome.

Most adults with alopecia have some quality of life impairment, mainly minimal to moderate, and are treated with minoxidil.

Tofacitinib is an effective and safe treatment for alopecia areata.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Taking medication for hair loss might cause sexual problems.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

FUE hair transplant is effective and safe for treating hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.